The Routine Clinical use of Pharmacogenetic Tests: What it Will Require?
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Routine Clinical use of Pharmacogenetic Tests: What it Will Require?
Authors
Keywords
biomarkers, clinical uptake, diagnostic tests, personalized medicine
Journal
PHARMACEUTICAL RESEARCH
Volume 34, Issue 8, Pages 1544-1550
Publisher
Springer Nature
Online
2017-02-25
DOI
10.1007/s11095-017-2128-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Meta-analysis of BRAF mutation as a predictive biomarker of benefit from anti-EGFR monoclonal antibody therapy for RAS wild-type metastatic colorectal cancer
- (2015) A Rowland et al. BRITISH JOURNAL OF CANCER
- Pharmacogenomics in the clinic
- (2015) Mary V. Relling et al. NATURE
- ExtendedRASmutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized, controlled trials
- (2014) M. J. Sorich et al. ANNALS OF ONCOLOGY
- Useless Until Proven Effective: The Clinical Utility of Preemptive Pharmacogenetic Testing
- (2014) A C J W Janssens et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Evidence Required to Demonstrate Clinical Utility of Pharmacogenetic Testing: The Debate Continues
- (2014) N K Gillis et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Cost–effectiveness of genotyping to guide treatment
- (2014) Michael J Sorich et al. PHARMACOGENOMICS
- Challenges and Limitations in the Interpretation of Systematic Reviews: Making Sense of Clopidogrel and CYP2C19 Pharmacogenetics
- (2013) M J Sorich et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The EGAPP initiative: lessons learned
- (2013) GENETICS IN MEDICINE
- Clinical delivery of pharmacogenetic testing services: a proposed partnership between genetic counselors and pharmacists
- (2013) Rachel Mills et al. PHARMACOGENOMICS
- Exploration of the perceptions, barriers and drivers of pharmacogenomics practice among hospital pharmacists in Adelaide, South Australia
- (2013) M M Dias et al. PHARMACOGENOMICS JOURNAL
- Interpreting the clinical utility of a pharmacogenomic marker based on observational association studies
- (2013) M J Sorich et al. PHARMACOGENOMICS JOURNAL
- The Coriell personalized medicine collaborative pharmacogenomics appraisal, evidence scoring and interpretation system
- (2013) Neda Gharani et al. Genome Medicine
- Adoption of Pharmacogenomic Testing by US Physicians: Results of a Nationwide Survey
- (2012) E J Stanek et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Personalized Medicine: Potential, Barriers and Contemporary Issues
- (2012) Michael J. Sorich et al. CURRENT DRUG METABOLISM
- Improving the efficiency and relevance of evidence-based recommendations in the era of whole-genome sequencing: an EGAPP methods update
- (2012) David L. Veenstra et al. GENETICS IN MEDICINE
- Germline pharmacogenomics in oncology: Decoding the patient for targeting therapy
- (2012) Peter H. O'Donnell et al. Molecular Oncology
- Development and implementation of a pharmacist-managed clinical pharmacogenetics service
- (2011) K. R. Crews et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Assessment of the Pharmacogenomics Educational Needs of Pharmacists
- (2011) Kristen B. McCullough et al. AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION
- Pharmacogenetic Testing: Time for Clinical Practice Guidelines
- (2011) U Amstutz et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network
- (2011) M V Relling et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Evolving Research and Stakeholder Perspectives on Pharmacogenomics
- (2011) Amber L. Beitelshees et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Knowledge and attitudes concerning pharmacogenomics among healthcare professionals
- (2011) Crystal Dodson Personalized Medicine
- Knowledge, attitudes and education of pharmacists regarding pharmacogenetic testing
- (2011) Mary W Roederer et al. Personalized Medicine
- Use of molecular markers for predicting therapy response in cancer patients
- (2010) Michael J. Duffy et al. CANCER TREATMENT REVIEWS
- Developing Pharmacogenetic Evidence Throughout Clinical Development
- (2010) D K Burns CLINICAL PHARMACOLOGY & THERAPEUTICS
- Assessing the Clinical Utility of Diagnostics Used in Drug Therapy
- (2010) J Woodcock CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Clinical Utility of Precision Medicine: Properly Assessing the Value of Emerging Diagnostic Tests
- (2010) B Shen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Establishing Clinical Utility of Pharmacogenetic Tests in the Post-FDAAA Era
- (2010) B J Evans CLINICAL PHARMACOLOGY & THERAPEUTICS
- What Is Clinical Utility and Why Should We Care?
- (2010) L J Lesko et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Outcomes of interest in evidence-based evaluations of genetic tests
- (2010) Jeffrey R Botkin et al. GENETICS IN MEDICINE
- Cancer Pharmacogenomics and Pharmacoepidemiology: Setting a Research Agenda to Accelerate Translation
- (2010) Andrew N. Freedman et al. JNCI-Journal of the National Cancer Institute
- Personalized Medicine and Genomics: Challenges and Opportunities in Assessing Effectiveness, Cost-Effectiveness, and Future Research Priorities
- (2010) Rena Conti et al. MEDICAL DECISION MAKING
- Application of a pharmacogenetic test adoption model to six oncology biomarkers
- (2010) Hawazin Faruki et al. Personalized Medicine
- Pharmacogenetics: from discovery to patient care
- (2009) Jaekyu Shin et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Pharmacists and pharmacogenetics
- (2009) M. W. Roederer AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Meta-analysis: Its strengths and limitations
- (2009) E. WALKER et al. CLEVELAND CLINIC JOURNAL OF MEDICINE
- Addressing the Challenges of the Clinical Application of Pharmacogenetic Testing
- (2009) ON Ikediobi et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Recommendations from the EGAPP Working Group: can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan?
- (2009) GENETICS IN MEDICINE
- Can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? An evidence-based review
- (2009) Glenn E Palomaki et al. GENETICS IN MEDICINE
- The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP Working Group
- (2009) Steven M Teutsch et al. GENETICS IN MEDICINE
- Evaluating the utility of personal genomic information
- (2009) Morris W Foster et al. GENETICS IN MEDICINE
- The role of meta-analysis in cancer clinical trials
- (2009) Chikuma Hamada International Journal of Clinical Oncology
- Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers
- (2009) R. M. Simon et al. JNCI-Journal of the National Cancer Institute
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
- (2009) Alessandro Liberati et al. PLOS MEDICINE
- A Personalized Approach to Cancer Treatment: How Biomarkers Can Help
- (2008) M. J. Duffy et al. CLINICAL CHEMISTRY
- Pharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment
- (2008) Jürgen Brockmöller et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Abacavir hypersensitivity: a model system for pharmacogenetic test adoption
- (2008) Myla Lai-Goldman et al. GENETICS IN MEDICINE
- Removing barriers to a clinical pharmacogenetics service
- (2008) William Newman et al. Personalized Medicine
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search